Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 8/20 | 0.72 |
| ▸ | MEN1 | O00255 | 5/20 | 0.72 |
| ▸ | MAPT | P10636 | 12/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 8/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 6/20 | 0.56 |
| ▸ | HTT | P42858 | 4/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.56 |
| ▸ | GAA | P10253 | 5/20 | 0.54 |
| ▸ | POLB | P06746 | 1/20 | 0.54 |
| ▸ | NPC1 | O15118 | 1/20 | 0.53 |
| ▸ | RAB9A | P51151 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 3/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.51 |
| ▸ | RECQL | P46063 | 1/20 | 0.49 |
| ▸ | ALPI | P09923 | 1/20 | 0.49 |
| ▸ | GFER | P55789 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sivifene SCHEMBL29386100 | 1.00 | KMT2A (0.72) | KMT2AMEN1MAPTMAPK1TDP1 | |
| SCHEMBL4109631 | 0.95 | KMT2A (0.66) | KMT2AMEN1MAPTMAPK1TDP1 | |
| SCHEMBL8591778 | 0.94 | KMT2A (0.65) | KMT2AMEN1MAPTMAPK1TDP1 | |
| SCHEMBL8591788 | 0.94 | KMT2A (0.65) | KMT2AMEN1MAPTMAPK1TDP1 | |
| SCHEMBL8591021 | 0.89 | KMT2A (0.62) | KMT2AMEN1MAPTMAPK1TDP1 | |
| SCHEMBL8594080 | 0.88 | KMT2A (0.57) | KMT2AMEN1MAPTMAPK1TDP1 | |
| SCHEMBL4132271 | 0.88 | KMT2A (0.60) | KMT2AMEN1MAPTMAPK1TDP1 | |
| SCHEMBL180084 | 0.87 | KMT2A (0.72) | KMT2AMEN1MAPTMAPK1TDP1 | |
| SCHEMBL180083 | 0.87 | KMT2A (0.72) | KMT2AMEN1MAPTMAPK1TDP1 | |
| SCHEMBL4132128 | 0.83 | KMT2A (0.58) | KMT2AMEN1MAPTMAPK1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2043 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230346800-A1 | REDUCTION OF THE INCIDENCE OR RECURRENCE OF BREAST CANCER IN POSTMENOPAUSAL WOMEN TREATED WITH INTRAVAGINAL SEX STEROID PRECURSOR | ENDORECHERCHE, INC. (CA) | 2023-11-02 | — | — | US | claimed |
| US-11690852-B2 | Reduction of the incidence or recurrence of breast cancer in postmenopausal women treated with intravaginal sex steroid precursor | ENDORECHERCHE. INC. | 2023-07-04 | — | — | US | claimed |
| US-20220313703-A1 | REDUCTION OF THE INCIDENCE OR RECURRENCE OF BREAST CANCER IN POSTMENOPAUSAL WOMEN TREATED WITH INTRAVAGINAL SEX STEROID PRECURSOR | ENDORECHERCHE, INC. (CA) | 2022-10-06 | — | — | US | claimed |
| CN-109982701-B | Application of SERD (serine-transferase) and CDK4/6 inhibitor and PI3K/mTOR pathway inhibitor | 江苏恒瑞医药股份有限公司 | 2022-04-12 | — | — | CN | claimed |
| EP-2805945-B1 | Amide substituted indazoles as poly(ADP-ribose)polymerase (PARP) inhibitors | MSD ITALIA SRL (IT) | 2019-04-03 | — | — | EP | claimed |
| EP-3458015-A1 | VAGINAL DELIVERY SYSTEMS CONTAINING SELECTIVE ESTROGEN RECEPTOR MODULATOR (SERM) AND USES THEREOF | Azure Biotech, Inc. (US) | 2019-03-27 | — | — | EP | claimed |
| US-20170333394-A1 | VAGINAL DELIVERY SYSTEMS CONTAINING SELECTIVE ESTROGEN RECEPTOR MODULATOR (SERM) AND USES THEREOF | Azure Biotech, Inc. | 2017-11-23 | — | — | US | claimed |
| WO-2017201508-A1 | VAGINAL DELIVERY SYSTEMS CONTAINING SELECTIVE ESTROGEN RECEPTOR MODULATOR (SERM) AND USES THEREOF | Azure Biotech, Inc. (US) | 2017-11-23 | — | — | WO | claimed |
| US-20140301976-A1 | NOVEL HYDROXAMATES AS THERAPEUTIC AGENTS | PHARMACYCLICS, INC. | 2014-10-09 | — | — | US | claimed |
| US-8779171-B2 | Hydroxamates as therapeutic agents | PHARMACYCLICS, INC. (US) | 2014-07-15 | — | — | US | claimed |
| US-20130142758-A1 | NOVEL HYDROXAMATES AS THERAPEUTIC AGENTS | PHARMACYCLICS, INC. (US) | 2013-06-06 | — | — | US | claimed |
| US-20090247641-A1 | HYDRAZONE AGENTS TO TREAT CUTANEOUS LESIONS | DEKK-TEC, INC. | 2009-10-01 | — | — | US | claimed |
| EP-1933824-A2 | HYDRAZONE AGENTS TO TREAT CUTANEOUS LESIONS | Dekk-Tec, Inc. (US) | 2008-06-25 | — | — | EP | claimed |
| US-20070078114-A1 | COMBINATION THERAPY FOR ALZHEIMER'S DISEASE AND OTHER DISEASES | MYRIAD GENETICS, INCORPORATED (US) | 2007-04-05 | — | — | US | claimed |
| WO-2007025186-A2 | HYDRAZONE AGENTS TO TREAT CUTANEOUS LESIONS | DEKK-TEC, INC. (US) | 2007-03-01 | — | — | WO | claimed |
| WO-1998058649-A1 | SALT COMPLEX FOR LYMPHATIC DELIVERY | DEKK-TEC, INC. (US) | 1998-12-30 | — | — | WO | claimed |
| US-20260132164-A1 | PNU ANTHRACYCLINE DERIVATIVES AND METHODS OF USE THEREOF | MERCK SHARP & DOHME LLC (US) | 2026-05-14 | — | — | US | disclosed |
| EP-4076459-B1 | PRMT5 INHIBITORS | MERCK SHARP & DOHME LLC (US) | 2026-04-29 | — | — | EP | disclosed |
| WO-1998058649-A1 | SALT COMPLEX FOR LYMPHATIC DELIVERY | DEKK-TEC, INC. (US) | 1998-12-30 | — | — | WO | disclosed |
| WO-1994005276-A1 | CYTOTOXIC COMPOUNDS | MORGAN LEE R (US) | 1994-03-17 | — | — | WO | disclosed |